| Jeffrey T Laseter, MD | |
|
2470 Flowood Drive, Flowood, MS 39232 | |
| (877) 554-4257 | |
| (601) 983-2845 |
| Full Name | Jeffrey T Laseter |
|---|---|
| Gender | Male |
| Speciality | Pain Management |
| Experience | 32 Years |
| Location | 2470 Flowood Drive, Flowood, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1710095880 | NPI | - | NPPES |
| P00034220 | Other | MS | RAILROAD MEDICARE |
| 00118315 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207LP2900X | Anesthesiology - Pain Medicine | 13537 (Mississippi) | Secondary |
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 13537 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mississippi Baptist Medical Center | Jackson, MS | Hospital |
| King's Daughters Medical Center-brookhaven | Brookhaven, MS | Hospital |
| St Dominic-jackson Memorial Hospital | Jackson, MS | Hospital |
| Merit Health River Oaks | Flowood, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Newsouth Neurospine, Llc | 2163591579 | 21 |
News Archive
Researchers from the University of Minnesota Medical School investigated the sex differences among patients with cardiac sarcoidosis, a multisystem, granulomatous disorder.
Researcher Christian Duval, PhD, and his team have developed a new, simple and non-invasive approach to create a biomechanical and cognitive profile of football players and more quickly and accurately detect concussions in these individuals. Christian Duval and his post-doctoral student Hung Nguyen, PhD, work at the Research Centre of the Institut universitaire de gériatrie de Montréal, which is affiliated with the University of Montreal.
An incisionless operation to patch stomach ulcers and potentially other perforations in the digestive tract may soon move into human trials at the Mayo Clinic in Rochester, MN. Clinical investigators reported on their research experience at the 95th annual Clinical Congress of the American College of Surgeons.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have created a device that significantly decreases the time needed to produce genetically manipulated T cells in preclinical tests for leukemia.
› Verified 3 days ago
| Entity Name | Newsouth Neurospine, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326222548 PECOS PAC ID: 2163591579 Enrollment ID: O20080527000108 |
News Archive
Researchers from the University of Minnesota Medical School investigated the sex differences among patients with cardiac sarcoidosis, a multisystem, granulomatous disorder.
Researcher Christian Duval, PhD, and his team have developed a new, simple and non-invasive approach to create a biomechanical and cognitive profile of football players and more quickly and accurately detect concussions in these individuals. Christian Duval and his post-doctoral student Hung Nguyen, PhD, work at the Research Centre of the Institut universitaire de gériatrie de Montréal, which is affiliated with the University of Montreal.
An incisionless operation to patch stomach ulcers and potentially other perforations in the digestive tract may soon move into human trials at the Mayo Clinic in Rochester, MN. Clinical investigators reported on their research experience at the 95th annual Clinical Congress of the American College of Surgeons.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have created a device that significantly decreases the time needed to produce genetically manipulated T cells in preclinical tests for leukemia.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey T Laseter, MD 2470 Flowood Drive, Flowood, MS 39232 Ph: (877) 554-4257 | Jeffrey T Laseter, MD 2470 Flowood Drive, Flowood, MS 39232 Ph: (877) 554-4257 |
News Archive
Researchers from the University of Minnesota Medical School investigated the sex differences among patients with cardiac sarcoidosis, a multisystem, granulomatous disorder.
Researcher Christian Duval, PhD, and his team have developed a new, simple and non-invasive approach to create a biomechanical and cognitive profile of football players and more quickly and accurately detect concussions in these individuals. Christian Duval and his post-doctoral student Hung Nguyen, PhD, work at the Research Centre of the Institut universitaire de gériatrie de Montréal, which is affiliated with the University of Montreal.
An incisionless operation to patch stomach ulcers and potentially other perforations in the digestive tract may soon move into human trials at the Mayo Clinic in Rochester, MN. Clinical investigators reported on their research experience at the 95th annual Clinical Congress of the American College of Surgeons.
Omni Bio Pharmaceutical, Inc., an emerging biopharmaceutical company formed to acquire, license, and develop existing therapies for indications with substantial commercialization potential, has committed to expand its Phase I/II human clinical trial in recently diagnosed Type 1 diabetes patients from 15 patients to 50.
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have created a device that significantly decreases the time needed to produce genetically manipulated T cells in preclinical tests for leukemia.
› Verified 3 days ago